1600418-29-8 (MC-Ggfg-DX8951,MC-GGFG-Exatecan)

MC-Ggfg-DX8951;Trastuzumab Impurity 1;BCP31889;MC-GGFG-Exatecan;MC-GGFG-DX-8951; MC-GGFG-DX 8951; MC-GGFG-DX;6-(2,5-dioxopyrrol-1-yl)-N-[2-[[2-[[(2S)-1-[[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]hexanamide;DA-75355;1600418-29-8;SCHEMBL17325024;MC-GGFG-DX8951?;HY-114233;CS-0080347;MS-31766;EX-A6238;AKOS040742108;

XEKFDUNPKACYAY-SODISJPWSA-N

1S/C49H51FN8O11/c1-3-49(68)31-19-36-45-29(24-58(36)47(66)30(31)25-69-48(49)67)44-33(14-13-28-26(2)32(50)20-34(56-45)43(28)44)54-40(62)23-53-46(65)35(18-27-10-6-4-7-11-27)55-39(61)22-52-38(60)21-51-37(59)12-8-5-9-17-57-41(63)15-16-42(57)64/h4,6-7,10-11,15-16,19-20,33,35,68H,3,5,8-9,12-14,17-18,21-25H2,1-2H3,(H,51,59)(H,52,60)(H,53,65)(H,54,62)(H,55,61)/t33-,35-,49-/m0/s1

FC1C([H])=C2C3=C(C=1C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(C3=C1C(C3=C([H])C4[C@](C(=O)OC([H])([H])C=4C(N3C1([H])[H])=O)(C([H])([H])C([H])([H])[H])O[H])=N2)N([H])C(C([H])([H])N([H])C([C@]([H])(C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])N([H])C(C([H])([H])N([H])C(C([H])([H])N([H])C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C(C([H])=C([H])C1=O)=O)=O)=O)=O)=O)=O